Po Shun Lee Net Worth

The estimated Net Worth of Po Shun Lee is at least $28.7 Tausend dollars as of 28 January 2019. Po Lee owns over 2,312 units of Proteostasis Therapeutics Inc stock worth over $21,762 and over the last 9 years Po sold PTI stock worth over $6,936.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Po Lee PTI stock SEC Form 4 insiders trading

Po has made over 1 trades of the Proteostasis Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Po sold 2,312 units of PTI stock worth $6,936 on 28 January 2019.

The largest trade Po's ever made was selling 2,312 units of Proteostasis Therapeutics Inc stock on 28 January 2019 worth over $6,936. On average, Po trades about 330 units every 0 days since 2016. As of 28 January 2019 Po still owns at least 2,312 units of Proteostasis Therapeutics Inc stock.

You can see the complete history of Po Lee stock trades at the bottom of the page.

What's Po Lee's mailing address?

Po's mailing address filed with the SEC is 200 TECHNOLOGY SQUARE, 4TH FLOOR, , CAMBRIDGE, MA, 02139.

Insiders trading at Proteostasis Therapeutics Inc

Over the last 9 years, insiders at Proteostasis Therapeutics Inc have traded over $9,140,918 worth of Proteostasis Therapeutics Inc stock and bought 12,301,024 units worth $94,383,855 . The most active insiders traders include M James Barrett, Llc Fmr und Bioventures Ltd Novartis Ag.... On average, Proteostasis Therapeutics Inc executives and independent directors trade stock every 36 days with the average trade being worth of $3,463,082. The most recent stock trade was executed by Enterprise Associates 12, L... on 26 November 2019, trading 1,283,919 units of PTI stock currently worth $3,222,637.

What does Proteostasis Therapeutics Inc do?

Complete history of Po Lee stock trades at Proteostasis Therapeutics Inc

Proteostasis Therapeutics Inc executives and stock owners

Proteostasis Therapeutics Inc executives and other stock owners filed with the SEC include:

• Meenu Chhabra,
  President, Chief Executive Officer, Director
• Marija Zecevic,
  Chief Operating Officer
• Benito Munoz,
  Chief Scientific Officer
• Jeffery Kelly,
  Independent Director
• Emmanuel Dulac,
  Independent Director
• Kimberlee Drapkin,
  Independent Director
• Badrul Chowdhury,
  Independent Director
• David Arkowitz,
  Independent Director
• Geoffrey Gilmartin,
  Chief Medical Officer
• Franklin Berger,
  Independent Chairman of the Board
• Eric Rabinowitz,
  Director
• Co Plc Perrigo Holdings Ltd...,
  
• M James Barrett,
  Director
• Asset Management, Lp Chen B...,
  
• James M. Detore,
  See Remarks
• Llc Fmr,
  
• Brett R Hagen,
  Principal Accounting Officer
• Po Shun Lee,
  See Remarks
• Bioventures Ltd Novartis Ag...,
  
• Enterprise Associates 12, L...,
  
• Eric D Larson,
  See Remarks
• Helen M Boudreau,
  Director
• Enterprise Associates 12, L...,
  
• Sheila Wilson,
  Chief Operating Officer
• Christopher T Phd Walsh,
  Director
• Janet L Smart,
  See Remarks
• Christopher Mirabelli,
  Director
• Romeo Mirzac,
  Principal Accounting Officer
• Christopher Health Care Ven...,
  
• Conor M Walshe,
  Director